2012
DOI: 10.1016/s0924-9338(12)75521-9
|View full text |Cite
|
Sign up to set email alerts
|

P-1354 - Comparative effects of venlafaxine and mirtazapine on sleep physiology measures in patients with major depresive disorder and insomnia

Abstract: Background: Sleep complaints are common in patients with major depressive disorder (MDD).Venlafaxine is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class. Mirtazapine is a tetracyclic antidepressant (TeCA) used primarily in the treatment of depression. This study compares the effects of venlafaxine and mirtazapine on sleep continuity measures in DSM-IV MDD patients with insomnia. Method: Patients (N=37) received initial baseline polysomnography evaluations over 2 consecutive nights.Sub… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Polysomnography studies were obtained at baseline, one, two, and eight weeks following medication initiation. At two weeks, the mirtazapine group was noted to have statistically significant improvements in sleep latency, sleep efficiency, and wake after sleep onset; whereas, the venlafaxine group did not -even by eight weeks (Miljatovic, 2012).…”
Section: Antidepressantsmentioning
confidence: 89%
“…Polysomnography studies were obtained at baseline, one, two, and eight weeks following medication initiation. At two weeks, the mirtazapine group was noted to have statistically significant improvements in sleep latency, sleep efficiency, and wake after sleep onset; whereas, the venlafaxine group did not -even by eight weeks (Miljatovic, 2012).…”
Section: Antidepressantsmentioning
confidence: 89%